We are pleased to announce that we’ve just launched a new course in the EHDEN Academy, teaching you how to use the ATLAS toolset. ATLAS is a free, publicly available web-based, open-source software application developed by the OHDSI community. ATLAS supports the design and execution of analyses across one or more observational databases which have … Read more
28 July 2020, Brussels, Belgium. Healthcare today is ever more complex, with growing expectations from our advancing insights into our own biology, diseases, their diagnosis, treatment and outcomes, and innovation in those treatments. Working within individual institutions to generate insights in the 21st century is much more challenging, hence collaboration, and at scale across multiple … Read more
22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data & Evidence Network (EHDEN) is delighted to announce its involvement in establishing a European framework and research network for the conduct of multicentre cohort studies on the use of medicines in COVID-19 patients. The European Medicines Agency (EMA) has announced a … Read more
David van Brunt Senior Research Fellow and Head, Division of Evidence and Analytics AbbVie Introduce yourself and AbbVie? AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s Mission is to use its expertise, dedicated people and a … Read more
EHDEN has a dedicated work package (WP) focusing on the outreach and the sustainability of the project as it is today and beyond the 5-year timeframe of the project. In this article, WP6 Leads, Johann Proeve and Carlos Diaz zoom in on the work done so far in these two important workstreams. To guide … Read more
15 June, 2020, Brussels, Belgium: From 16 April – 14 May, EHDEN announced a rolling COVID-19 Rapid Collaboration Call. Its goal is to help clinicians, scientists, governments and the public to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. Upon conclusion of … Read more
As covered in Part l of the series, the world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage … Read more
Gözde Susuzlu Briggs Project Coordinator European Patients Forum Introduce yourself and your the European Patients Forum? I’m Gözde Susuzlu, Project Coordinator at the European Patients Forum (EPF), based in Brussels, Belgium. I contribute to EHDEN and other digital health and health data related projects, such as DigitalHealthEurope and the Data Saves Lives initiative. The diversity … Read more
19 May, 2020, Brussels, Belgium: Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe and effective. To help provide these answers, EHDEN announced a rolling COVID-19 Rapid Collaboration Call, which ran from 16 April – 14 … Read more
The world is still very much fighting the SARS-CoV- 2 pandemic, and in many countries, is still striving to deal with a growing number of COVID-19 patients. Clinicians, scientists, governments and the public all want to know more about characterising patients with COVID-19, how best to manage their care, and if certain treatments are safe … Read more